KLK3 and Familial prostate cancer: Exosome Diagnostics (a Bio-Techne brand) recognized an opportunity to utilize exRNA as a predictive marker for prostate cancer and developed a urine exosome gene expression assay that can identify higher-grade prostate cancer among patients with elevated prostate-specific antigen (PSA) levels.